Investigating how certain microRNAs are degraded in T-cell leukemia
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
This study is looking at how tiny molecules called microRNAs affect T-cell acute lymphoblastic leukemia (T-ALL) and aims to find new ways to make chemotherapy work better for patients by understanding how a specific mRNA interacts with these microRNAs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10886091 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of microRNAs in T-cell acute lymphoblastic leukemia (T-ALL), a type of cancer affecting the blood and bone marrow. The team will explore how a specific mRNA, BIM, can degrade two microRNAs that are typically involved in cancer progression. By examining this unique interaction, the researchers aim to uncover new strategies for enhancing the effectiveness of chemotherapy treatments. Additionally, they will develop methods to identify other mRNAs that may influence microRNA levels in T-ALL patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with T-cell acute lymphoblastic leukemia who are undergoing or considering chemotherapy.
Not a fit: Patients with other types of leukemia or those not currently receiving treatment for T-ALL may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved chemotherapy outcomes for patients with T-cell acute lymphoblastic leukemia.
How similar studies have performed: While the specific approach of mRNA-induced microRNA degradation is novel, similar research has shown promise in understanding gene regulation in cancer.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Xie, Mingyi — University of Florida
- Study coordinator: Xie, Mingyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.